1. Amyloidosis: a global problem common in Papua New Guinea
K. P. McAdam ; J. G. Raynes ; M. P. Alpers ; G. T. Westermark ; P. Westermark
Papua New Guinea medical journal 1996;39(4):284-296
The increase in different precursor proteins that have been shown to form amyloid fibrils and the identification of common properties have not yet led to any unifying theory or mechanism for the pathogenesis of amyloidogenesis. Papua New Guinea holds a unique place in the story of amyloidosis and in this article we review the current status of amyloidosis research indicating how this relates to those forms relevant to Papua New Guinea. This review concentrates on secondary reactive amyloid (AA), which is found in the highest frequency in the world in parts of Papua New Guinea, and kuru, in which the amyloid protein itself is infectious. The history, pathogenesis and future prospects for these diseases are discussed in the light of what is known about other forms of amyloidosis
Amyloid beta-Peptides
;
Amyloid - genetics
;
Global Health
;
Humans
;
Mutation
;
Papua New Guinea - epidemiology
;
Serum Amyloid A Protein
2.Secondary renal amyloidosis in a 13-year-old girl with bronchiectasis.
Eun Ae YANG ; Dong Won LEE ; Myung Chul HYUN ; Min Hyun CHO
Korean Journal of Pediatrics 2010;53(7):770-773
A 13-year-old girl was diagnosed with non-cystic fibrosis (CF)-related multifocal bronchiectasis accompanied by nephrotic-range proteinuria of unknown cause. On renal biopsy, there were many segmental homogeneous deposits of amyloid tissue with positive Congo red staining in the glomeruli and interstitium. On electron microscopy, relatively straight, non-branching, randomly arranged amyloid fibrils were showed in the mesangium of the glomeruli. These fibrils were approximately 10 nm in diameter, compatible with secondary amyloidosis. Her level of serum amyloid A was remarkably elevated. To our knowledge, this girl is the first case of secondary renal amyloidosis induced by bronchiectasis in Korean children.
Adolescent
;
Amyloid
;
Amyloidosis
;
Biopsy
;
Bronchiectasis
;
Child
;
Congo Red
;
Fibrosis
;
Humans
;
Microscopy, Electron
;
Proteinuria
;
Serum Amyloid A Protein
3.Serum Amyloid A Circulating Levels and Disease Activity in Patients with Juvenile Idiopathic Arthritis.
Luca CANTARINI ; Teresa GIANI ; Antonella FIORAVANTI ; Francesca IACOPONI ; Gabriele SIMONINI ; Ilaria PAGNINI ; Adriano SPREAFICO ; Federico CHELLINI ; Mauro GALEAZZI ; Rolando CIMAZ
Yonsei Medical Journal 2012;53(5):1045-1048
The aim of our study was to evaluate the association between circulating levels of serum amyloid A protein (SAA) and disease activity in patients with juvenile idiopathic arthritis (JIA). Our study group included 41 JIA patients (9 male, 32 female), classified according to the International League of Associations for Rheumatology (ILAR) criteria (5); 16 had polyarticular onset disease and 25 had oligoarticular onset disease. Among 25 patients with oligoarticular disease, three had extended oligoarthritis. Serum amyloid A (SAA), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured in both patients and 26 healthy controls. SAA levels were higher in JIA patients versus healthy controls (p<0.001). Significant positive correlations were found between SAA and the presence of active joints (rho=0.363, p<0.05), the number of active joints (rho=0.418, p<0.05), ESR (R=0.702, p<0.05) and CRP (R=0.827, p<0.05). No significant correlations between ESR and the presence of active joints (rho=0.221, p=0.225) or between ESR and the number of active joints (rho=0.118, p=0.520) were demonstrated in JIA patients. No significant correlations were obtained between CRP and the presence of active joints (rho=0.034, p=0.855) or between CRP and the number of active joints (rho=0.033, p=0.859). We discovered a significant increase in SAA levels in JIA patients, compared to controls, and a strong positive correlation between SAA level and JIA disease activity. We also discerned SAA to be a more sensitive laboratory marker than ESR and CRP for evaluating the presence and number of active joints. We suggest that SAA can be used as an additional indicator of disease activity in JIA.
Arthritis, Juvenile*
;
Biomarkers
;
Blood Sedimentation
;
C-Reactive Protein
;
Humans
;
Joints
;
Male
;
Rheumatology
;
Serum Amyloid A Protein*
4.Association between Coronary Artery Abnormality and Serum Amyloid A in Kawasaki Disease.
Jin suk SUH ; Hwa young JEE ; Ohgun KWON ; Hae yong LEE
Journal of the Korean Pediatric Cardiology Society 2007;11(3):229-234
PURPOSE: Kawasaki disease can cause cardiovascular complications if not properly treated from the beginning. Recently, serum amyloid A(SAA) was reported to be a predictive factor of cardiovascular diseases. Therefore, it was examined whether the existence of coronary artery abnormality in Kawasaki disease can be predicted in acute stage. METHODS: Forty nine patients who were diagnosed with Kawasaki disease between October, 2006 and May, 2007 at Yonsei University, Wonju College of Medicine were selected for this study. We reviewed results of CBC, AST, ALT, CK, LDH, total bilirubin, albumin, CRP, CK-MB, troponin-I, LDL, HDL, SAA, ESR. We divided the patients into two groups: Group A consisting of patients with coronary artery lesions, and group B consisting of patients without coronary artery lesions. RESULTS: CRP was significantly higher in group A (group A 11.0+/-7.0 mg/dL vs group B 5.3+/-5.3 mg/dL, P=0.030). SAA was slightly higher in group A but did not show any statistical significance (group A 283.8+/-357.3 microgram/mL vs group B 133.2+/-293.4 microgram/mL, P=0.128). Binary regression analysis was used to identify the significance of SAA as a predictor of coronary artery abnormality but did not find any significance (SAA OR=1.000, 95% CI=0.998-1.002, P=0.950). CONCLUSION: SAA are not significant predictors of coronary artery abnormality in Kawasaki disease but are non specific factors which increase in the acute stage.
Amyloid
;
Bilirubin
;
Cardiovascular Diseases
;
Coronary Vessels*
;
Gangwon-do
;
Humans
;
Mucocutaneous Lymph Node Syndrome*
;
Serum Amyloid A Protein*
;
Troponin I
5.Decrease in Serum Amyloid a Protein Levels Following Three-month Stays in Negatively Charged Particle-dominant Indoor Air Conditions.
Suni LEE ; Shoko YAMAMOTO ; Yasumitsu NISHIMURA ; Hidenori MATSUZAKI ; Kei YOSHITOME ; Tamayo HATAYAMA ; Miho IKEDA ; Min YU ; Nagisa SADA ; Naoko KUMAGAI-TAKEI ; Takemi OTSUKI
Biomedical and Environmental Sciences 2018;31(5):335-342
OBJECTIVEThe changes in serum adipokines and cytokines related to oxidative stress were examined during 3 months 'Off to On' and 'On to Off' periods using negatively charged particle-dominant indoor air conditions (NCPDIAC).
METHODSSeven volunteers participated in the study, which included 'OFF to 3 months ON' periods (ON trials) for a total of 16 times, and 'ON to 3 months OFF' (OFF trials) periods for a total of 13 times.
RESULTSWith the exception of one case, serum amyloid A (SAA) levels decreased significantly during the ON trials.
CONCLUSIONConsidering that SAA is an acute phase reactive protein such as C reactive protein (CRP), this observed decrease might indicate the prevention of cardiovascular and atherosclerotic changes, since an increase in high-sensitive CRP is associated with the subsequent detection of these events.
Adult ; Air ; analysis ; Air Pollution, Indoor ; Environmental Monitoring ; Female ; Housing ; Humans ; Male ; Serum Amyloid A Protein ; metabolism
6.A Case of Macroglossia due to Amyloidosis Associated with Multiple Myeloma.
Rok Young KIM ; John Jae Woon LEE ; Dong Hoon LEE ; Joon Kyoo LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 2013;56(1):37-40
Amyloidosis is a condition of abnormal deposition of extracellular insoluble fibrillar proteins, termed amyloid, in tissue and organs throughout the body. Systemic amyloidosis, consisting of light amyloid protein (AL protein), the spectrum of multiple myeloma and plasmacytoma, is categorized as a primary amyloidosis; secondary amyloidosis consists of an acute phase reactant serum amyloid A protein (AA protein), which is associated with neoplasm. Amyloid involvement of the tongue is almost always secondary to systemic AL amyloidosis. Macroglossia due to amyloid depositions can lead to serious airway obstruction. We report a case of a 68-year-old woman suffering from dyspnea due to macroglossia. She was diagnosed with amyloidosis associated with multiple myeloma.
Airway Obstruction
;
Amyloid
;
Amyloidosis
;
Dyspnea
;
Female
;
Humans
;
Light
;
Macroglossia
;
Multiple Myeloma
;
Plaque, Amyloid
;
Plasmacytoma
;
Proteins
;
Serum Amyloid A Protein
;
Stress, Psychological
;
Tongue
7.Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study.
Qiu Yan CHEN ; Qing Nan TANG ; Lin Quan TANG ; Wen Hui CHEN ; Shan Shan GUO ; Li Ting LIU ; Chao Feng LI ; Yang LI ; Yu Jing LIANG ; Xue Song SUN ; Ling GUO ; Hao Yuan MO ; Rui SUN ; Dong Hua LUO ; Yu Ying FAN ; Yan HE ; Ming Yuan CHEN ; Ka Jia CAO ; Chao Nan QIAN ; Xiang GUO ; Hai Qiang MAI
Cancer Research and Treatment 2018;50(3):701-711
PURPOSE: The measuring Epstein-Barr virus (EBV) DNA is an important predictor of nasopharyngeal carcinoma (NPC). This study evaluated the predictive value of pretreatment serum amyloid A (SAA) and C-reactive protein (CRP) comparing with EBV DNA in patients with NPC. MATERIALS AND METHODS: In an observational study of 419 non-metastatic NPC patients, we prospectively evaluated the prognostic effects of pretreatment SAA, CRP, and EBV DNA on survival. The primary end-point was progress-free survival (PFS). RESULTS: The median level of SAA and CRP was 4.28 mg/L and 1.88 mg/L, respectively. For the high-SAA group (> 4.28 mg/L) versus the low-SAA (≤ 4.28 mg/L) group and the high-CRP group (> 1.88 mg/L) versus the low-CRP (≤ 1.88 mg/L) group, the 5-year PFS was 64.5% versus 73.1% (p=0.013) and 65.2% versus 73.3% (p=0.064), respectively. EBV DNA detection showed a superior predictive result, the 5-year PFS in the EBV DNA ≥ 1,500 copies/mL group was obviously different than the EBV DNA < 1,500 copies/mL group (62.2% versus 77.8%, p < 0.001). Multifactorial Cox regression analysis confirmed that in the PFS, the independent prognostic factors were including EBV DNA (hazard ratio [HR], 1.788; p=0.009), tumour stage (HR, 1.903; p=0.021), and node stage (HR, 1.498; p=0.049), but the SAA and CRP were not included in the independent prognostic factors. CONCLUSION: The results of SAA and CRP had a certain relationship with the prognosis of NPC, and the prognosis of patients with high level of SAA and CRP were poor. However, the predictive ability of SAA and CRP was lower than that of EBV DNA.
C-Reactive Protein*
;
DNA*
;
Herpesvirus 4, Human*
;
Humans
;
Observational Study
;
Prognosis
;
Prospective Studies*
;
Serum Amyloid A Protein*
;
Survival Analysis
8.Diagnosis of bacterial and viral infection by HNL, SAA, PCT and CRP combined test.
Jia Hao GUAN ; Xiao Jun DANG ; Juan MA ; Si Ruo ZHANG ; Ling LI ; Ping ZHANG ; Li Xia ZHANG
Chinese Journal of Preventive Medicine 2023;57(12):2153-2158
The value of combined detection of neutrophil apolipoprotein (HNL), serum amyloid A (SAA), procalcitonin (PCT) and C-reactive protein (CRP) in the differential diagnosis of bacterial and viral infectious diseases. A retrospective study was conducted to collect the clinical data of infected patients and healthy people in the clinical department of Shaanxi Provincial People's Hospital from September to December in 2022. 100 patients with confirmed infection were divided into bacterial infection group (n=50) and virus infection group (n=50), and 50 healthy people were selected as control group (n=50). Fasting venous blood was collected at the initial stage of admission or on the day of physical examination. HNL was detected by double antibody sandwich method, SAA and CRP were detected by nephelometry, and PCT was detected by chemiluminescence method. The efficacy of infection markers in the differential diagnosis of bacterial infection and viral infection in infected patients was evaluated. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic efficacy of HNL, SAA, PCT and CRP in bacterial and viral infectious diseases; Logistic regression was used to analyze the influence of each index on the diagnostic efficiency. The results showed that the levels of HNL (126.60±33.32) ng/ml, PCT (28.02±11.37) ng/ml and CRP (36.13±14.37) mg/L in bacterial infection group were significantly higher than those of HNL (47.72±15.94) ng/ml, PCT (1.27±0.40) ng/ml, CRP (18.77±10.66) mg/L in virus group and HNL (38.21±12.53) ng/ml, PCT (0.38±0.12) ng/ml and CRP (4.13±1.07) mg/L in control group. The level of HNL increased most significantly (F=89.228, P<0.05). The area under ROC curve (AUC) from large to small was HNL+SAA+PCT+CRP (0.976), HNL (0.907), PCT (0.885), CRP (0.856), SAA (0.790), SAA/CRP (0.733). The level of SAA/CRP in virus infection group (94.05±3.75) was significantly higher than that in bacteria group (17.70±3.69) and control group (3.89±1.50) (F=84.005, P<0.05). The area under ROC curve (AUC) from large to small was HNL+SAA+PCT+CRP (0.986), SAA/CRP (0.956), SAA (0.878), HNL (0.768), CRP (0.742), PCT (0.730). In conclusion, HNL has the best auxiliary diagnostic efficacy in bacterial infection, followed by PCT; SAA/CRP has the best auxiliary diagnostic efficacy in viral infection, followed by SAA; the combined detection of serum HNL, SAA, PCT and CRP may be helpful for the differential diagnosis of bacterial and viral infections.
Humans
;
C-Reactive Protein
;
Procalcitonin
;
Serum Amyloid A Protein
;
Retrospective Studies
;
Virus Diseases/diagnosis*
;
Bacteria
;
Communicable Diseases
;
Bacterial Infections/diagnosis*
9.Diagnosis of bacterial and viral infection by HNL, SAA, PCT and CRP combined test.
Jia Hao GUAN ; Xiao Jun DANG ; Juan MA ; Si Ruo ZHANG ; Ling LI ; Ping ZHANG ; Li Xia ZHANG
Chinese Journal of Preventive Medicine 2023;57(12):2153-2158
The value of combined detection of neutrophil apolipoprotein (HNL), serum amyloid A (SAA), procalcitonin (PCT) and C-reactive protein (CRP) in the differential diagnosis of bacterial and viral infectious diseases. A retrospective study was conducted to collect the clinical data of infected patients and healthy people in the clinical department of Shaanxi Provincial People's Hospital from September to December in 2022. 100 patients with confirmed infection were divided into bacterial infection group (n=50) and virus infection group (n=50), and 50 healthy people were selected as control group (n=50). Fasting venous blood was collected at the initial stage of admission or on the day of physical examination. HNL was detected by double antibody sandwich method, SAA and CRP were detected by nephelometry, and PCT was detected by chemiluminescence method. The efficacy of infection markers in the differential diagnosis of bacterial infection and viral infection in infected patients was evaluated. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic efficacy of HNL, SAA, PCT and CRP in bacterial and viral infectious diseases; Logistic regression was used to analyze the influence of each index on the diagnostic efficiency. The results showed that the levels of HNL (126.60±33.32) ng/ml, PCT (28.02±11.37) ng/ml and CRP (36.13±14.37) mg/L in bacterial infection group were significantly higher than those of HNL (47.72±15.94) ng/ml, PCT (1.27±0.40) ng/ml, CRP (18.77±10.66) mg/L in virus group and HNL (38.21±12.53) ng/ml, PCT (0.38±0.12) ng/ml and CRP (4.13±1.07) mg/L in control group. The level of HNL increased most significantly (F=89.228, P<0.05). The area under ROC curve (AUC) from large to small was HNL+SAA+PCT+CRP (0.976), HNL (0.907), PCT (0.885), CRP (0.856), SAA (0.790), SAA/CRP (0.733). The level of SAA/CRP in virus infection group (94.05±3.75) was significantly higher than that in bacteria group (17.70±3.69) and control group (3.89±1.50) (F=84.005, P<0.05). The area under ROC curve (AUC) from large to small was HNL+SAA+PCT+CRP (0.986), SAA/CRP (0.956), SAA (0.878), HNL (0.768), CRP (0.742), PCT (0.730). In conclusion, HNL has the best auxiliary diagnostic efficacy in bacterial infection, followed by PCT; SAA/CRP has the best auxiliary diagnostic efficacy in viral infection, followed by SAA; the combined detection of serum HNL, SAA, PCT and CRP may be helpful for the differential diagnosis of bacterial and viral infections.
Humans
;
C-Reactive Protein
;
Procalcitonin
;
Serum Amyloid A Protein
;
Retrospective Studies
;
Virus Diseases/diagnosis*
;
Bacteria
;
Communicable Diseases
;
Bacterial Infections/diagnosis*
10.A Case of Secondary Amyloidosis Associated with Intestinal Tuberculosis.
Jungkwon KIM ; Seung Jae MYUNG ; Jungjoon CHOI ; Gideog KIM ; Dongryoul OH ; Sujin KOH ; Won Jang KIM ; Jintae PARK ; Ginhyuk LEE ; Suk Kyun YANG ; Weon Seon HONG ; Jin Ho KIM ; Young Il MIN ; Jooryung HUH
Korean Journal of Gastrointestinal Endoscopy 2003;27(4):244-248
The secondary amyloidosis (AA type), a complication of inflammation or infection, is caused by the deposition of serum amyloid protein A in various organs. The clinical manifestations of amyloidosis are various according to involved organs. The gastrointestinal tract is one of the commonly affected organs. However, the endoscopic findings of gastrointestinal amyloidosis are nonspecific, and symptoms are diverse. Hepatic involvement of amyloidosis rarely leads to hepatic dysfunction, threfore is not a clinical concern. We report a 54-year-old women with intestinal tuberculosis whose major symptom was watery diarrhea lasting several months. The amyloid deposits were histologically proven in the rectum of which mucosa showed redness and swelling endoscopically and hepatic involvement of amyloidosis was suspected on abdominopelvic CT scan. After anti-tuberculosis medication for 6 months, abdominopelvic CT scan showed resolution of hepatic involvement and colonoscopy revealed improvement of redness and loss of vascularity of the rectum.
Amyloidosis*
;
Colonoscopy
;
Diarrhea
;
Female
;
Gastrointestinal Tract
;
Humans
;
Inflammation
;
Middle Aged
;
Mucous Membrane
;
Plaque, Amyloid
;
Rectum
;
Serum Amyloid A Protein
;
Tomography, X-Ray Computed
;
Tuberculosis*